Affiliation:
1. Hideki Ueno and Hidetaka Mochizuki, National Defense Medical College, Tokorozawa; Kazuo Shirouzu, Kurume University Faculty of Medicine, Kurume; Takaya Kusumi, Keiyukai Sapporo Hospital, Sapporo; Kazutaka Yamada, Coloproctology Center, Takano Hospital, Kumamoto; Masahiro Ikegami, Jikei University School of Medicine; Hiroshi Kawachi and Kenichi Sugihara, Tokyo Medical and Dental University; Shingo Kameoka, Tokyo Women's Medical University; Yasuo Ohkura and Tadahiko Masaki, Kyorin University, School of...
Abstract
PurposeTo clarify the prognostic impact of tumor nodules without residual lymph node (LN) structure (ND) in colorectal cancer and to determine optimal categorization of ND in tumor staging.Patients and MethodsA multicenter, retrospective pathologic review was performed for 1,716 patients with stages I to III curatively resected colorectal cancer treated at 11 institutions between 1994 and 1998. An additional 2,242 patients from nine institutions were enrolled between 1999 and 2003 as a second cohort to validate the results.ResultsLN metastasis (LNM) and ND were observed in 33.7% and 16.0% (smooth-contour nodule [S-ND], 8.2%; irregular-contour nodule [I-ND], 10.7%) of patients in the first cohort. S-ND and I-ND were similarly distributed in the regional area. There was no considerable difference in the impact on survival between S-ND (hazard ratio [HR], 2.7; 95% CI, 1.9 to 3.8) and I-ND (HR, 4.3; 95% CI, 3.3 to 5.8) or between LNM (HR, 4.5; 95% CI, 3.4 to 6.0) and ND (HR, 4.0; 95% CI, 3.1 to 5.3). LNM and ND were similarly associated with the mode of recurrence. Tumor nodules ≥ 5 mm growing with venous/perineural invasion (ND [v/pni+]), judged with 0.61 κ value among 11 observers, had an independent prognostic value for 5-year survival of 42%; similar results were observed in the second cohort.ConclusionThese results do not support the TNM system in which S-ND is treated differently from I-ND in tumor staging; LNM and ND should be considered together in the same category. The presence of ND (v/pni+) has a considerable adverse prognostic effect.
Publisher
American Society of Clinical Oncology (ASCO)
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献